Kappa-opiate agonists for the treatment of bladder diseases

Details Kappa-opiate agonists for the treatment of bladder diseases Kappa-opiate agonists for the treatment of bladder diseases

A - Human Necessities

61

K

A61K 31/40 (2006.01) A61P 13/10 (2006.01)

Patent

CA 2443019

The invention relates to the use of a medicament n-methyl-N-[(1S)-1-phenyl- 2((3S)-3-hydroxypyrrolidin-1-yl)-ethyl]-2,2-diphenyl-acetamide or one of the pharmacologically acceptable salts thereof for the production of medicament formulations for the treatment of bladder diseases, particularly irritable bladder syndrome and the pains associated therewith.

L'invention concerne l'utilisation du principe actif N-méthyl-N-[(1S)-1-phényl-2((3S)-3-hydroxypyrrolidin-1-yl)-éthyl]-2,2-diphényl-acétamide ou d'un de ses sels pharmacologiquement tolérables pour préparer des formulations de médicaments servant à traiter les affections de la vessie, notamment la vessie irritable et les douleurs qui y sont liées.

Affiliated with

Also associated with

Rating

Kappa-opiate agonists for the treatment of bladder diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kappa-opiate agonists for the treatment of bladder diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa-opiate agonists for the treatment of bladder diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1724266